Diamonds and Dogs
6/28/13Blackberry Inc. (BBRY)
Blackberry is leaving a sour taste in investor's mouths today, down 27.70% at $10.47. The mobile phone company saw its shares drop its newest cell phone, Blackberry 10, sales fell short of estimates. BlackBerry 10 smartphones amounted to about 40% of total smartphone shipments; which would equate to about 2.7 million units. Analysts had been expecting about 3.3 million BB10 units to ship in the period. The lower shipments are leading analysts to believe the company will show a loss for the quarter, prior to the lower sales numbers Wall Street expected Blackberry to be in the green. The company's shares fell over $4.00 today.
Halozyme Therapeutics Inc. (HALO)
Halozyme is skyrocketing today, up 24.49% at $7.93. The biopharmaceutical company saw its shares jump after news that its development partner, Roche, received a positive recommendation from a European drug regulator for the administration of its breast cancer drug through subcutaneous injection. The positive recommendation was from the European Medicines Agency's Committee for Medicinal Products for Human Use. The companies say that a typical intravenous infusion of Herceptin SC for patients with breast cancer can take 30 minutes to 90 minutes per dose. However, that time compares with administration taking two minutes to five minutes when delivered subcutaneously by injection under the skin.